Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)-Reference-Cited by-同舟云学术

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)

Published:2020-12-14 Issue:3 Volume:31 Page:223-238
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Sun Xin¹,Xu Shan¹,Yang Zunhua²,Zheng Pengwu¹,Zhu Wufu¹

Affiliation:

1. Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China

2. College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi

Science and Technology Project

Education Department of Jiangxi Province

Nanchang Key Laboratory of Molecular Targeted Anticancer Drug Design and Evaluation

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1860210

Reference92 articles.

1. Recent advances in the management of lung cancer

2. Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)

3. Mechanism of taxane neurotoxicity

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain;Cell Communication and Signaling;2024-08-27

2. Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells;Tropical Journal of Pharmaceutical Research;2024-06-25

3. EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring;Frontiers in Oncology;2024-06-24

4. Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC;Advanced Science;2024-02-13

5. A concise review on anti-breast cancer effectiveness of s-triazines through EGFR kinase inhibition;Medicinal Chemistry Research;2023-12-21